Αποτελέσματα Αναζήτησης
3 Οκτ 2024 · You are up to date when you have received: 1 dose of the 2024–2025 Moderna COVID-19 vaccine OR. 1 dose of the 2024–2025 Pfizer-BioNTech COVID-19 vaccine OR. 1 dose of the 2024–2025 Novavax vaccine unless you are receiving a COVID-19 vaccine for the very first time.
For individuals age 5 or older who are not immunocompromised and have never been vaccinated against COVID-19, the CDC recommends one dose of the updated 2024–2025 COVID-19 vaccine. If you are moderately or severely immunocompromised, it is recommended you receive an initial vaccination series.
6 Σεπ 2024 · The COVID-19 vaccination schedule for people who are not moderately or severely immunocompromised is detailed in Table 1. The recommended vaccine and number of 2024–2025 COVID-19 vaccine doses are based on age and vaccination history. Table 1.
27 Αυγ 2024 · The following recipients of an mRNA primary series may receive a COVID-19 vaccine booster dose at least 6 months after completing their primary series based on their individual risks and benefits: People aged 18–49 years with certain underlying medical conditions.
Starting Saturday, November 20 nearly 10,000 CVS Pharmacy locations across the country will be able to offer a Pfizer-BioNTech or Moderna COVID-19 booster dose to all adults ages 18 years and older who have completed primary vaccination with any authorized COVID-19 vaccine.
WOONSOCKET, R.I., SEPT. 13, 2023 — CVS Health® (NYSE: CVS) today announced that the updated COVID-19 vaccine recently authorized by the FDA and recommended by the CDC is now available at its CVS Pharmacy locations.
As of September 12, 2023, updated COVID-19 vaccines are now available that more closely target currently circulating variants. Based on the Centers for Disease Control and Prevention (CDC) guidelines, eligible patients can receive a single dose of an updated mRNA COVID-19 vaccine at least two months after their last dose of a COVID-19 vaccine.
